Aespira

Company Overview

Snapshot

Founded in January 2007, Aespira operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its pipeline of inhaler products.

Business overview

Aespira is a Health Tech & Life Sciences company developing a pipeline of inhaler products utilizing generic drugs. Its core technology, ActiveMesh, enables the packaging of dry-powder drugs within a mesh-based system that disperses fine particles through breath-driven beating. The company is also developing the resQhaler, a disposable, whistle-shaped inhaler device designed for effective breath-synchronized drug delivery with audible confirmation. Aespira's solutions aim to prevent contamination, simplify usage for non-trained patients, and facilitate single-dose or non-chronic applications, serving the medical devices, drug delivery, and pharmaceutical biotechnology sectors.

Company Intelligence Q&A

What is Aespira's primary focus?

Aespira is focused on developing a pipeline of inhaler products that use generic drugs, aiming for ease of use, contamination prevention, and suitability for single-dose or non-chronic applications.

What is the ActiveMesh technology?

ActiveMesh is Aespira's proprietary technology for packaging dry-powder drugs within a mesh-based system. This technology uses the breath-driven beating of the package to sieve and release fine dry-powder particles for inhalation.

What is the resQhaler device?

The resQhaler is a disposable and hygienic whistle-shaped inhaler device developed by Aespira. It integrates the ActiveMesh technology to ensure effective breath-synchronized drug delivery with audible confirmation.

What problem does Aespira aim to solve with its inhaler products?

Aespira's inhalers are designed to address issues such as contamination, complexity for non-trained patients, and the need for efficient single-dose or non-chronic drug delivery in respiratory treatments.

What is Aespira's current stage of development?

Aespira is currently in the R&D stage for its products, with its funding stage classified as Pre-Funding.